Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
$13.17
+0.4%
$11.51
$6.64
$35.52
$12.87M1.87479,845 shs17,400 shs
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
$1.63
-3.6%
$0.20
$0.20
$0.75
$36.12M1.96915,302 shs24,611 shs
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
$4.57
+5.5%
$3.80
$2.70
$11.68
$8.60M2.2623,217 shs91,978 shs
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$0.04
$0.09
$0.02
$1.82
$862K1.4721.72 million shs44.20 million shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
0.00%0.00%0.00%0.00%0.00%
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
0.00%-6.32%-12.83%-26.91%+517.42%
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
+5.54%+28.01%+10.12%+52.33%-60.87%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-9.09%+73.52%-58.92%-87.84%-97.90%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/AN/AN/AN/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
N/AN/AN/AN/A
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
N/AN/AN/AN/A
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
2.00
HoldN/AN/A

Current Analyst Ratings

Latest CYTX, SINT, NURO, and APOP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/5/2024
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
N/AN/AN/AN/A$4.77 per shareN/A
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
$3.67M9.84N/AN/A$0.35 per share4.66
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
$5.90M1.54N/AN/A$13.18 per share0.35
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$2.63M0.33N/AN/A$1.65 per share0.02

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
-$5.62MN/A0.00N/AN/AN/AN/AN/A
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
-$12.63MN/A0.00N/A-242.60%-272.70%-56.23%N/A
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
-$6.53M-$6.23N/AN/A-110.64%-31.31%-29.32%5/1/2024 (Estimated)
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$8.26M-$3.42N/AN/A-314.39%-67.12%-45.49%5/20/2024 (Estimated)

Latest CYTX, SINT, NURO, and APOP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/27/2024Q4 2023
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A-$0.09-$0.09-$0.09N/A$0.90 million
2/22/2024Q4 2023
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/A-$1.43-$1.43-$1.43N/A$1.32 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
N/AN/AN/AN/AN/A
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
N/AN/AN/AN/AN/A
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
N/A
3.01
3.01
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
0.39
0.46
0.30
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/A
16.80
15.55
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A
1.90
1.60

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
4.84%
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
2.62%
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
19.40%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
18.38%

Insider Ownership

CompanyInsider Ownership
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
N/A
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
0.66%
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
4.40%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
0.79%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cellect Biotechnology Ltd. stock logo
APOP
Cellect Biotechnology
2,020977,000N/ANot Optionable
Cytori Therapeutics Inc stock logo
CYTX
Cytori Therapeutics
3722.16 millionN/ANot Optionable
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
261.99 million1.90 millionNot Optionable
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
4122.68 million22.50 millionNot Optionable

CYTX, SINT, NURO, and APOP Headlines

SourceHeadline
Why SINTX Technologies Stock Is Getting HammeredWhy SINTX Technologies Stock Is Getting Hammered
msn.com - April 3 at 2:48 PM
SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common StockSINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock
globenewswire.com - April 3 at 9:00 AM
Why SINTX Technologies Stock Hit A New All-Time Low TodayWhy SINTX Technologies Stock Hit A New All-Time Low Today
msn.com - April 1 at 3:51 PM
DDC Appoints Vice President to Drive Operational ExcellenceDDC Appoints Vice President to Drive Operational Excellence
itnewsonline.com - March 30 at 6:23 PM
SINTX Technologies Announces Proposed Public Offering of Common StockSINTX Technologies Announces Proposed Public Offering of Common Stock
globenewswire.com - March 29 at 4:00 PM
SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023
investorplace.com - March 28 at 7:02 AM
Sintx Technologies Prices Public Offering Of $1.3 Mln Of SharesSintx Technologies Prices Public Offering Of $1.3 Mln Of Shares
markets.businessinsider.com - March 25 at 1:22 PM
Why SINTX Technologies Stock Is Down 50%Why SINTX Technologies Stock Is Down 50%
msn.com - March 25 at 1:22 PM
Why Is Sintx Technologies (SINT) Stock Down 31% Today?Why Is Sintx Technologies (SINT) Stock Down 31% Today?
investorplace.com - March 25 at 9:05 AM
SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common StockSINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock
globenewswire.com - March 25 at 9:00 AM
US Stocks Edge Lower; FedEx Posts Upbeat EarningsUS Stocks Edge Lower; FedEx Posts Upbeat Earnings
msn.com - March 23 at 3:15 AM
Why SINTX Technologies Is Trading Higher TodayWhy SINTX Technologies Is Trading Higher Today
aol.com - March 22 at 10:14 PM
Gold Moves Lower; Lululemon Shares PlummetGold Moves Lower; Lululemon Shares Plummet
msn.com - March 22 at 5:14 PM
Dow Dips 200 Points; Nike Shares Fall After Q3 ResultsDow Dips 200 Points; Nike Shares Fall After Q3 Results
markets.businessinsider.com - March 22 at 5:14 PM
SINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%SINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%
markets.businessinsider.com - March 22 at 5:14 PM
Why SINTX Technologies Stock Is NosedivingWhy SINTX Technologies Stock Is Nosediving
msn.com - March 22 at 5:14 PM
SINTX Technologies Announces Proposed Public Offering of Common StockSINTX Technologies Announces Proposed Public Offering of Common Stock
globenewswire.com - March 22 at 8:30 AM
Sintx Technologies (SINT) Price Target Increased by 42.86% to 10.20Sintx Technologies (SINT) Price Target Increased by 42.86% to 10.20
msn.com - February 24 at 2:14 PM
Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)
benzinga.com - February 23 at 7:50 AM
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
finance.yahoo.com - February 21 at 3:58 PM
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
globenewswire.com - February 21 at 9:00 AM
SINTX Technologies: Other EventsSINTX Technologies: Other Events
cbonds.com - February 16 at 10:37 AM
SINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturingSINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturing
tctmagazine.com - February 7 at 10:57 AM
Sintx Technologies just downgraded at Maxim, heres whySintx Technologies just downgraded at Maxim, here's why
realmoney.thestreet.com - February 5 at 5:59 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cellect Biotechnology logo

Cellect Biotechnology

NASDAQ:APOP
Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.
Cytori Therapeutics logo

Cytori Therapeutics

NASDAQ:CYTX
Cytori Therapeutics, Inc. is a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in San Diego, CA.
NeuroMetrix logo

NeuroMetrix

NASDAQ:NURO
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Sintx Technologies logo

Sintx Technologies

NASDAQ:SINT
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.